|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues: | |||||
| Information services and others | |||||
| Reservation services | |||||
| Information, reservation services and others | |||||
| Aesthetic Treatment Services | |||||
| Sales of medical products and maintenance services | |||||
| Other services | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Information and reservation services | |||||
| Cost of services and others | |||||
| Cost of information, reservation services and others | |||||
| Cost of aesthetic treatment services | |||||
| Other services | |||||
| Cost of medical products sold and maintenance services | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing expenses | |||||
| Nonrelated party | |||||
| Total sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Nonrelated party | |||||
| Total general and administrative expenses | |||||
| Research and development expenses | |||||
| Impairment of goodwill | |||||
| Impairment of goodwill and long-lived assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income/(expenses): | |||||
| Investment income, net | |||||
| Interest income, net | |||||
| Exchange (losses)/gains | |||||
| Impairment of long-term investment | |||||
| Share of losses of equity method investee | |||||
| Others, net | |||||
| Income/(Loss) before tax | |||||
| Income tax benefits/(expenses) | |||||
| Net income/(loss) | |||||
| Net (income)/loss attributable to non-controlling interests | |||||
| Net income/(loss) attributable to So-Young International Inc. | |||||
| Other comprehensive income/(loss): | |||||
| Foreign currency translation adjustment | |||||
| Total other comprehensive income/(loss) | |||||
| Total comprehensive income / (loss): | |||||
| Comprehensive (income)/loss attributable to non-controlling interests | |||||
| Comprehensive income/(loss) attributable to So-Young International Inc. | |||||
| Net earnings/(loss) per ordinary share | |||||
| Net earnings/(loss) per ordinary share attributable to So-Young International Inc. - basic | |||||
| Ordinary shares | |||||
| American Depository Shares | |||||
| Net earnings/(loss) per ordinary share attributable to So-Young International Inc. - diluted | |||||
| Ordinary shares | |||||
| American Depository Shares | |||||
| Weighted average number of ordinary shares used in computing earnings/(loss) per share, basic* | |||||
| Weighted average number of ordinary shares used in computing earnings/(loss) per share, diluted* | |||||
| Share-based compensation expenses included in: | |||||
| Share-based compensation expenses | |||||
| Cost of revenues | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Research and development expenses | |||||
| Share-based compensation expense, portion recorded as cost of sales | |||||
| Share-based compensation expense, portion recorded as selling and marketing expense | |||||
| Share-based compensation expense, portion recorded as general and administrative expense | |||||
| Share-based compensation expense, portion recorded as research and development expense | |||||
Loading...